Status:
RECRUITING
An Observational Study of Inflammatory Bowel Disease (IBD) Patients With Non-alcoholic Fatty Liver Disease (NAFLD)
Lead Sponsor:
Shanghai East Hospital
Collaborating Sponsors:
Shanghai Pudong New Area Health Commission
Dongfang Hospital Affiliated to Tongji University
Conditions:
Inflammatory Bowel Disease (IBD)
Metabolic Dysfunction Associated Fatty Liver Disease
Eligibility:
All Genders
18+ years
Brief Summary
Inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn's disease, are currently of unknown etiology and incurable. In recent years, the incidence of IBD has increased dramatically i...
Eligibility Criteria
Inclusion
- Subjects aged over 18 years (including borderline values), of either sex.
- Subjects consistented with the Chinese consensus on the diagnosis and treatment of IBD;
- Subjects able to cooperate with follow-up, participate in this study and sign the informed consent.
Exclusion
- Subjects with incomplete clinical data;
- Subjects can not to cooperate with follow-up, and refuse to sign the informed consent;
- Subjects can not to cooperate with the completion of relevant examinations; 4 Pregnant women;
- Subjects with severe heart, lung, kidney and other organ diseases or cancer, and expected survival time less than 6 months.
Key Trial Info
Start Date :
May 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
337 Patients enrolled
Trial Details
Trial ID
NCT06939569
Start Date
May 1 2025
End Date
December 1 2027
Last Update
April 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai East Hospital
Shanghai, China